Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease.
C HurabielleF Sicre de FontbruneH Moins-TeisserencM RobinM JachietT ComanN DhedinCharles CassiusF ChassetA de MassonD MichonneauM BagotA BergeronG SociéR Peffault de LatourJean-David BouazizPublished in: The British journal of dermatology (2017)
Keyphrases